论文信息 - A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML - 字舞流文

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

M. Tormo | M. Voso | J. Cavenagh | W. Copeland | A. Zeidan | S. Rose | L. Silverman | I. Boss | A. Hellmann | B. Fox | D. Taussig | C. Beach | Ethan G. Thompson | Vanessa E Hasle | Tim O'Connor | Aessandro Previtali | T. O'Connor | A. Previtali | C. Beach | C.L. Beach | Vanessa E. Hasle